www.fdanews.com/articles/130928-epigenomics-signs-agreement-with-nextpharma-for-epi-procolon

Epigenomics Signs Agreement With NextPharma for Epi proColon

October 8, 2010

Epigenomics AG, a Germany-based cancer molecular diagnostics company, and NextPharma Technologies have signed a global manufacturing agreement for Epigenomics’ Epi proColon product.
TradingMarkets